For our patients undergoing cancer treatment, what role do antioxidant substances play? Further, should we encourage or actively discourage these patients from taking them? Dr. Brian Lawenda, assistant professor of radiation oncology at the Indiana University School of Medicine, discusses the rationale for and against the use of antioxidants in patients receiving both chemotherapy and radiation therapy with your host, Dr. Lee Freedman.
For our patients undergoing cancer treatment, what role do antioxidant substances play? Further, should we encourage or actively discourage these patients from taking them? Dr. Brian Lawenda, assistant professor of radiation oncology at the Indiana University School of Medicine, discusses the rationale for and against the use of antioxidants in patients receiving both chemotherapy and radiation therapy with your host, Dr. Lee Freedman.
Facebook Comments